Hemagen Diagnostics, Inc. (HMGN)

Hemagen Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Feb 9, 2026	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008
Market Capitalization	0	1	0	1	1	2
Market Cap Growth	-97.50%	16.78%	-49.92%	-23.92%	-33.27%	-27.27%
Enterprise Value	-	5	5	5	6	6
Last Close Price	0.00	0.04	0.03	0.06	0.08	0.12
PE Ratio	-	-	-	-	-	4.28
PS Ratio	0.00	0.13	0.09	0.18	0.23	0.29
PB Ratio	0.00	-0.15	-0.17	-0.50	-0.68	-1.67
P/OCF Ratio	-	-	-	-	72.50	6.88
EV/Sales Ratio	-	1.35	0.97	0.99	1.04	0.99
EV/EBITDA Ratio	-	-	-	12.89	-	28.04
EV/EBIT Ratio	-	-	-	21.84	-	53.60
Debt / Equity Ratio	-1.41	-1.41	-1.76	-2.41	-2.51	-4.23
Debt / EBITDA Ratio	-	-	-	11.12	-	20.53
Asset Turnover	1.52	1.52	1.64	1.47	1.28	1.43
Inventory Turnover	1.72	1.72	2.23	1.85	1.70	1.57
Quick Ratio	0.34	0.34	0.52	0.70	0.54	0.17
Current Ratio	1.07	1.07	1.61	2.37	1.95	0.61
Return on Assets (ROA)	-10.27%	-10.27%	-9.44%	4.16%	-2.75%	1.66%
Return on Invested Capital (ROIC)	-30.32%	-27.18%	-22.15%	9.46%	-6.25%	3.80%
Return on Capital Employed (ROCE)	-88.80%	-88.80%	-34.70%	10.70%	-8.20%	-12.10%
Earnings Yield	-29268.23%	-167.24%	-189.53%	-16.85%	-66.28%	23.38%
FCF Yield	-14507.23%	-82.90%	-84.72%	-27.74%	-8.04%	-5.64%
Buyback Yield / Dilution	-0.13%	-0.13%	-0.14%	-1.44%	-0.03%	-0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.